Daniel Loeb’s Zimmer Biomet ZBH Stock Holding History

Daniel Loeb’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-927,000	Closed	-$132M	–	110
2021 Q3	$132M	Buy	927,000 +103,000	+13%	+$15.2M	0.72%	33
2021 Q2	$129M	Buy	+824,000	New	+$133M	0.75%	37

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Daniel Loeb's ZBH Position: Q4 2021 in Review

Daniel Loeb sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 927,000 shares — an estimated $132M sold.

Daniel Loeb first reported a position in ZBH in Q2 2021 and held it in 2 quarters. The position peaked at $132M in Q3 2021. 999 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Daniel Loeb reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Daniel Loeb sold 927,000 Zimmer Biomet shares in Q4 2021, an estimated $132M.
Daniel Loeb first reported a position in Zimmer Biomet in Q2 2021 and held it in 2 quarters.
Daniel Loeb's Zimmer Biomet position peaked at $132M in Q3 2021.
999 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Third Point's 13F filing for Q4 2021, filed 14 Feb 2022.